This inventor holds 1 USPTO granted patent. Top assignee: Kineta, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Adam Shultz Adler: Inventor in Cancer Immunotherapy
Introduction
Adam Shultz Adler is an inventor associated with South San Francisco, California. His patent work concerns antibodies targeting V-domain Ig-containing Suppressor of T cell Activation (VISTA), an immune-regulatory protein being studied in cancer treatment.
Latest Patents
Adler is associated with 1 patent: “Anti-vista antibodies and uses thereof.” The disclosure describes antibodies that specifically bind to VISTA, compositions containing those antibodies, and methods for using them to treat diseases, including cancer.
Career Highlights
Adler is associated with Kineta, Inc., a biotechnology company. His patent reflects work on antibody-based approaches that may help address immune regulation in disease.
Collaborations
The listed coworkers associated with Adler include Shawn P. Iadonato and Thierry Guillaudeux.
Conclusion
Adam Shultz Adler’s patent activity centers on VISTA-targeting antibodies and their potential use in treating cancer and other diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile